The SAFE-T Study: How low can we go with steroid therapy? 2024
0:00
2:25 Project background: Steroid reduction.
4:36 Project objectives: Improve safety of treatment of AAV.
5:19 Provide alternative options for GC-sparing regimens.
6:01 Methods and steps.
8:57 Potential benefits of this study.
10:48 Support for this project.
12:11 What is meant by induction therapy? When a doctor first diagnoses a patient how does he/she determine the dosage of steroids needed to be most effective?
16:03 Is one of the goals where newly diagnosed patients could start on a much lower dose of steroids but still achieve control over the inflammation?
19:56 Does the doctor imagine a day when steroids will be eliminated and replaced with another type of therapy (medication) that will be just as effective as steroids, but without the side effects?
25:20 Steroid therapy—how low can we go?
26:07 Is the SAFE-T Study related to the PEXIVAS Trial?
29:23 Are you getting closer to the phase where you will be recruiting patients?
30:58 How did you become interested in nephrology?
The SAFE-T Study: How low can we go with steroid therapy?
August 2024
Addendum: Read a VF article about David Massicotte-Azarniouch
and his current study at: https://tinyurl.com/2sdrxcfb